
WisdomTree Q3 AUM reaches record $171 billion as EPS hits $0.32
Key points
- WisdomTree (NYSE:WT) reported record assets under management of $171 billion in Q3 2026, increasing 5% from the previous quarter.
- Diluted earnings per share reached $0.32, while net income totalled $49.2 million and operating revenue increased 1.3% to $179.4 million.
- Year-to-date net inflows exceeded $13.6 billion, representing a 13% annualized organic growth rate, as the company expanded operating margins and returned capital to shareholders.
WisdomTree (NYSE:WT) reported record assets under management of $171 billion for the third quarter of 2026, alongside diluted earnings per share of $0.32 and net income of $49.2 million.
Assets under management increased 5% from the previous quarter, supported by $4.6 billion in quarterly net inflows and market appreciation, while operating revenue rose 1.3% to $179.4 million.
The company reported a year-to-date operating income margin of 39.8%, compared with 33% in the same period last year, while its adjusted margin increased to 41.8% from 34.3%.
WisdomTree generated more than $13.6 billion in net inflows during the first nine months of 2026, representing a 13% annualized organic growth rate, while its average advisory fee remained at 0.36%.
The company retired $18.1 million in convertible senior notes due 2029 for $32.3 million in cash, repurchased approximately 500,000 shares for $10.6 million and declared a quarterly dividend of $0.03 per share.
The dividend is payable November 25, 2026, to shareholders of record on November 11.
WisdomTree operates as a global asset manager offering exchange-traded funds, exchange-traded products and other investment solutions, with its portfolio spanning fixed income, commodities and equity markets.
Frequently asked questions
More from United States
Oil prices extend gains as Middle East tensions rise
Magna posts higher Q3 earnings despite 4% sales decline
BP Q3 profit jumps to $8.46 billion as debt falls
Sanofi Q3 sales rise 16.2% to €14.44 billion
AstraZeneca revenue advances 7% in Q3 to $16.21 billion
First Northern profit climbs 11.1% to $16.8 million
-1-640x358.jpg&w=3840&q=75)



-640x358.jpg&w=3840&q=75)